Nigeria

Resilience System


You are here

Science

Experts call for faster mobilisation of “overlooked” survivors to contain Ebola epidemic

OXFORD UNIVERSITY PRESS                                                                                  Dec, 10, 2014

In an editorial published online today in the International Journal of Epidemiology, experts from the Departments of Psychiatry and Epidemiology at Columbia University, New York, are calling for survivors of the Ebola epidemic to be mobilised in a bid to hasten containment of the disease.

We already know that the current Ebola outbreak is unique in its magnitude and for its dispersion in dense, mobile populations. Physicians and nurses face high mortality, and foreign aid in the form of medical supplies and staff continues to be unequal to the scope of the problem. With a case recovery rate of around 30% at the present time in West Africa, survivors already number in the thousands.

Problem, Solution, SitRep, or ?: 

WHO: malaria gains 'at risk' in Ebola-affected countries

MEDICAL NEWS TODAY                                                                                                 Dec. 9, 2014

LONDON --Thanks to increased disease control, global deaths to malaria have fallen dramatically, and the number of new cases is steadily declining, say the World Health Organization in a new report. Also, an increasing number of countries are moving toward eliminating the mosquito-borne disease altogether. But the UN agency warns these gains are fragile, and no more so than in countries worse-affected by the Ebola crisis.

 
A new report from the World Health Organization says the number of lives claimed by malaria worldwide fell by 47% between 2000 and 2013, and by 54% in Africa, where the vast majority of deaths occur.

The 2014 World Health Organization (WHO) report says deaths to malaria worldwide fell by 47% between 2000 and 2013. In the WHO African Region, where 90% of deaths to malaria occur, the reduction is 54%.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Rapid Ebola test is focus of NIH grant to Rutgers scientist

REPORTS Of RESEARCH ON TWO METHODS OF RAPID TESTING FOR EBOLA

(Two items, scroll down)

MEDICAL PRESS                                                                                     Dec. 8, 2014

Rutgers researcher David Alland, working with the California biotechnology company Cepheid, has received a grant of nearly $640,000 from the National Institutes of Health to develop a rapid test to diagnose Ebola as well as other viruses that can cause symptoms similar to Ebola.

Researchers will adapt this cartridge, now used worldwide for tuberculosis screenings, to collect and test samples from potential Ebola patients. Credit: John Emerson

Alland, a professor of medicine and associate dean for clinical research at Rutgers New Jersey Medical School and the principal investigator of the project, says would be able to take the test to small villages and other remote locations where the spread of Ebola has been especially rampant and diagnose patients where they live...

Meeting / Event Tags: 
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Assessing the Science of Ebola Transmission

THREE ARTICLES DESCRIBING DETAILS OF THE EBOLA VIRUS AND OTHER VIRUSES.
(Scroll Down)

Advances in microscopy have allowed scientists like Sriram Subramaniam and colleagues at the National Cancer Institute to look at the workings of tiny viruses. In this case, microscopy was used to illustrate the complex process in which human cells infected with HIV-1, green and blue, are linked to uninfected cells. Credit Illustration by Donald Bliss/N.I.H, from The Journal of Virology/American Society for Microbiology

The research on how the virus spreads is not as ambiguous as some have made it seem

THE ATLANTIC                                                                                                          Oct. 28, 2014

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

French scientists roll out rapid diagnostic test for Ebola

 FIERCE DIAGNOSTICS                            Oct. 23, 2014

By

French scientists are developing a diagnostic tool that works similar to a home pregnancy test and can quickly identify the virus through a tiny fluid sample.

 

  CEA's Ebola testing kit uses strips to rapidly identify the presence of the virus in fluid samples.--Courtesy of France's Atomic Energy  Commission

France's Atomic Energy Commission (CEA) is teaming up with European pharma company Vedalab to roll out a user-friendly testing system than could diagnose Ebola in less than 15 minutes, the agency said in a statement. The kit, dubbed "Ebola eZYSCREEN," includes a hand-held device that reads small samples of blood, plasma or urine to detect the virus, and shows results in stripes through a window on the tool.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Review of Human-to-Human Transmission of Ebola Virus

CDC                                                              Posted Oct. 20, 2014 from  CDC  Oct. 17 document

This document is a concise summary of published information on the current science about human-to-human transmission of Ebola virus. It is developed for use by healthcare personnel and public health professionals to use. It is a complement to the many guidance documents that CDC has issued already online at

www.cdc.gov/ebola.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Canada to start shipping experimental Ebola vaccine on Monday

CANADIAN PRESS                                     Oct. 18, 2014

OTTAWA—The federal government says Canada will start shipping its experimental Ebola vaccine to the World Health Organization on Monday.

 

 A lab worker at the JC Wilt Infectious Diseases Research centre at Canada's National Microbiology Laboratory in Winnipeg, Manitoba. An experimental Ebola vaccine developed in Canada will be shipped to the World Health Organization in Geneva starting Monday.

The government says in a release the Public Health Agency of Canada is supplying the vaccine to the UN body in Geneva in its role as the international co-ordinating body for the Ebola outbreak in West Africa. It says Canada will ship 800 vials of its experimental vaccine in three separate shipments, as a precautionary measure.

The WHO will consult with its partners, including the health authorities from the affected countries, to determine how best to distribute and use the vaccine. For instance, it must take into account concerns about using an experimental vaccine in people.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Science
howdy folks